Invex Therapeutics Ltd has released a press release.
Japanese Patent Granted
Filed with ASX ·
6ix hasn’t read this filing yet.
Invex Therapeutics Ltd. on 6ix
Earlier from Invex Therapeutics
Later from Invex Therapeutics
- Phase II Recruitment Completed
- Appendix 4D and Half-year Report
- Exenatide Meets Key Endpoints in IIH Clinical Trial
- Succesful $26 million Share Placement
- Phase II Clinical Results and Capital Raising Presentation
Follow Invex Therapeutics into a list and get an email when it puts out news.
Follow Invex Therapeutics